NCT00763750 - PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2012

Conditions

Brain Tumor

Interventions

DRUG

PPX +TMZ+XRT

PPX 50 mg/m2/week x 6 weeks (Days #1, 8, 15, 22, 29, 36) XRT: 60 Gy at 2 Gy/fraction x 30 fractions Temozolomide 75 mg/m2/day: Day #1 of XRT until completion (including weekends and holidays)

Trial Locations (1)

02906

Lifespan Hospitals, Providence